MD up +0.42% percent Today $MD High is at 62.84 and the Low

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MD up +0.42% percent Today $MD High is at 62.84 and the Low 62.24 with current volume of 108,645.

Recent News posted below.

Mednax Inc MD other info.
http://investorshangout.com/Mednax-Inc-MD-51757/

MD Mednax Inc Recent Headline News

Shares of MD Up 13.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 12, 9:28AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 3 weeks, Mednax has returned 13.83% as of today's recent price of $61.89.
MD: 62.80 (+0.47)

MEDNAX to Present at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 18, 2014 at 11:30 a.m. EST to investors attending the Stifel 2014 Healthcare Conference in New York.
MD: 62.80 (+0.47)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Mednax Is Up 1.1% (MD)
Comtex SmarTrend(R) - Mon Nov 10, 1:47PM CST
When Mednax (NYSE:MD) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.85 on sales of $619.3 million. Mednax actually reported earnings of $0.86 per share on sales of $626.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $7.2 million. Since the company's report, shares of Mednax have risen from $61.50 to $62.18, representing a gain of 1.1% in the past 11 days.
MD: 62.80 (+0.47)

MEDNAX to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Fri Nov 07, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 11, 2014 at 4:30 p.m. MST to investors attending the 2014 Credit Suisse Healthcare Conference in Phoenix.
MD: 62.80 (+0.47)

Mednax: Improving Bargaining Position, But Some Risks Ahead
Investing Doc - Seeking Alpha - Wed Nov 05, 10:38AM CST
My previous investment thesis for Mednax (NYSE: MD ) remains intact after reviewing the company's third quarter results, and while shares are less attractive than they had been after last week's jump in price, I still view them as undervalued after...
MD: 62.80 (+0.47)

Mednax Shares Up 15.4% Since SmarTrend's Buy Recommendation (MD)
Comtex SmarTrend(R) - Wed Nov 05, 9:33AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 2 weeks, Mednax has returned 15.42% as of today's recent price of $62.76.
MD: 62.80 (+0.47)

MEDNAX's (MD) CEO Roger Medel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 1:30PM CDT

MD: 62.80 (+0.47)

NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
CALX: 10.99 (+0.26), NFX: 33.64 (+0.74), EGL: 44.10 (+0.57), V: 249.13 (-1.79), MPLX: 68.27 (+1.07), GNC: 43.36 (-0.30), VHI: 5.80 (+0.15), ROG: 72.16 (+0.18), ACCO: 9.00 (+0.20), CEB: 74.19 (-0.18), FLTX: 37.19 (+0.21), MD: 62.80 (+0.47)

Mednax (MD) Marked As A Barbarian At The Gate
at The Street - Thu Oct 30, 9:46AM CDT
Trade-Ideas LLC identified Mednax (MD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MD: 62.80 (+0.47)

Mednax (MD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:55AM CDT

MD: 62.80 (+0.47)

Mednax beats Street 3Q forecasts
Automated Insights - Thu Oct 30, 5:54AM CDT
SUNRISE, Fla. (AP) _ Mednax Inc. (MD) on Thursday reported earnings of $86.2 million in its third quarter.
MD: 62.80 (+0.47)

Mednax beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:18AM CDT

MD: 62.80 (+0.47)

MEDNAX Reports 2014 Third Quarter EPS of $0.86
Business Wire - Thu Oct 30, 5:01AM CDT
--Credit Facility Expanded to $1.5 Billion
MD: 62.80 (+0.47)

Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 70.11 (+0.91), ESRX: 78.03 (+0.13), DVA: 75.84 (-1.20), DGX: 62.57 (-1.20), MD: 62.80 (+0.47)

MEDNAX Announces Acquisition of Anesthesiology Practice in Georgia
Business Wire - Wed Oct 29, 6:00AM CDT
MEDNAX, Inc. (NYSE: MD) today announced the signing of a definitive agreement to acquire The NEXus Medical Group, LLC and its subsidiary, Meridian Anesthesia Consultants, LLC in Macon, Georgia.
MD: 62.80 (+0.47)

MedData Launches iPhone App to Improve Billing Reconciliation for Surgical Practices
Business Wire - Thu Oct 23, 8:02AM CDT
MedData, Inc., a leading national provider of "patient-focused" revenue cycle management and patient financial lifecycle services, announced the launch of Patient Lists, a new iPhone app designed to streamline the medical billing process for its surgical clients.
MD: 62.80 (+0.47)

Edgemont Capital Partners Completes Sale of Premier Physician Services to TeamHealth
Business Wire - Wed Oct 22, 5:01PM CDT
Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Physician Services, Inc. ("Premier" in the sale of the company to TeamHealth Holdings Inc. (NYSE:TMH). Terms of the transaction were not disclosed.
EVHC: 32.70 (+0.25), TMH: 54.39 (+0.48), MD: 62.80 (+0.47)

MEDNAX Announces Acquisition of Perinatology Practice in Texas
Business Wire - Mon Oct 20, 6:00AM CDT
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Houston Perinatal Associates, P.A., a private physician group practice based in Houston, Texas. The practice will become part of MEDNAX's Pediatrix Medical Group division.
MD: 62.80 (+0.47)

HCA Holdings Gives Peek into Q4 Earnings, 2014 Guide Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 3:15PM CDT
HCA Holdings, Inc. (HCA) announced its preliminary financial and operating results for the third quarter of 2014.
ACHC: 61.53 (+0.24), HCA: 63.12 (-1.65), THC: 46.97 (-0.97), MD: 62.80 (+0.47)

MEDNAX 2014 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 30, 2014
Business Wire - Thu Oct 09, 6:00AM CDT
MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, October 30, 2014 at 10:00 a.m. EDT, to discuss results from operations for the quarter and the nine months ended September 30, 2014. A detailed press release will be issued the morning of October 30, 2014 before the securities markets open.
MD: 62.80 (+0.47)

Mednax Inc (MD) Stock Research Links

MD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocky Shore Gold Completes Initial Private Placement Tranche

Updated Category News Views 118

Rocky Shore Gold Completes Initial Private Placement Tranche Rocky Shore Gold Ltd. (CSE: RSG) has successfully announced the completion of the first tranche of its non-brokered private placement, raising significant funds to support its ongoing projects. The financing initiative, which was previously publicized, demonstrates the company's commitment to advancing its...

Continue Reading
Monthly Dividend Announcement from Ellington Credit Company

Updated Category News Views 185

Ellington Credit Company Declares Monthly Dividend Ellington Credit Company (NYSE: EARN) has made an exciting announcement regarding its financial commitment to its shareholders. The company's Board of Trustees has declared a monthly common dividend, establishing an amount of $0.08 per share. This dividend will be payable shortly, offering a tangible return to those...

Continue Reading
Halide Alagoz Sells Over $1.5 Million in Ralph Lauren Shares

Updated Category News Views 128

Halide Alagoz Completes Significant Stock Sale Recent reports indicate that Halide Alagoz, the Chief Product Officer at Ralph Lauren, executed a substantial insider sale according to official filings. Details of the Insider Transaction According to regulatory disclosures, Alagoz sold 5,282 shares of Ralph Lauren, resulting in a total transaction value of approximately...

Continue Reading
Midland States Bancorp, Inc. Declares Quarterly Dividends

Updated Category News Views 86

Midland States Bancorp, Inc. Declares Quarterly Cash Dividend Midland States Bancorp, Inc. (NASDAQ: MSBI) recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend is significant as it highlights the company’s commitment to delivering value to its shareholders. The payment will be available to shareholders of record on a...

Continue Reading
Standex International Sees Price Target Increase Amid Growth

Updated Category News Views 55

Standex International's Price Target Raised by DA Davidson Recently, Standex International (NYSE: SXI) experienced a notable increase in its price target, now set at $222.00, from analysts at DA Davidson. This update follows the company's fiscal year 2025 earnings report, coinciding with their performance in the third quarter of the calendar year. The previous price...

Continue Reading